section name header

Indications ⬇

REMS


Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: pruritus, rash

MS: extremity pain

Neuro: drowsiness

Misc: HYPERSENSITIVITY REACTIONS (INCLUDING ANAPHYLAXIS), infusion reactions

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

Route/Dosage ⬆ ⬇

Action ⬆ ⬇

  • A monoclonal antitoxin that blocks the activity of toxin produced by Bacillus anthracis. The toxin is a primary cause of disease progression.
Therapeutic effects:
  • Decreased morbidity and mortality associated with inhalational anthrax exposure and disease.

Classifications ⬆ ⬇

Therapeutic Classification: antidotes

Pharmacologic Classification: monoclonal anti-toxins

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability.

Distribution: Some tissue distribution.

Metabolism/Excretion: No renal clearance.

Half-Life: 20.4 days

Time/Action Profile ⬆ ⬇

(plasma concentrations)

ROUTEONSETPEAKDURATION
IVrapidend of infusionunknown



Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

rax-ee-BAK-ue-mab